B-MS inks fibrosis pact with Calibr
Bristol-Myers Squibb has linked up with the California Institute for Biomedical Research to develop anti-fibrotic therapies. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/b-ms_inks_fibrosis_pact_with_calibr_970805